ClinConnect ClinConnect Logo
Search / Trial NCT00566956

Ultrasound-guided Hydrosalpinx Aspiration During Egg Collection

Launched by BIRMINGHAM WOMEN'S NHS FOUNDATION TRUST · Nov 30, 2007

Trial Information

Current as of June 04, 2025

Terminated

Keywords

Hydrosalpinx/Ivf/Reproductive Outcome. Hydrosalpinx

ClinConnect Summary

· What we do not know: Treatment of hydrosalpinx and IVF Several studies in the literature have suggested that the treatment of hydrosalpinx pre-IVF would improve the pregnancy rate to a level similar to tubal disease patients without hydrosalpinx. The treatment modalities explored were salpingectomy, salpingostomy, tubal occlusion and ultrasound-guided aspiration either one month before or at the time of egg collection. All studies reported to date have been retrospective and with poor control design. A prospective randomised controlled trial is needed. All modalities have been associated ...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • healthy women, ASA class 1 (normal healthy) or class 2 (with mild systemic disease);
  • undergoing IVF or ICSI and reaching the stage of egg collection;
  • with ultrasonically diagnosed hydrosalpinx and identifiable during the phase of ovarian stimulation;
  • giving written informed consent.
  • Exclusion Criteria:
  • patients not giving written informed consent;
  • patients cancelled for poor ovarian response;
  • ultrasonically diagnosed hydrosalpinx and identifiable for the first time at egg-collection

About Birmingham Women's Nhs Foundation Trust

Birmingham Women's NHS Foundation Trust is a leading healthcare organization dedicated to providing high-quality women's and neonatal services. Committed to advancing clinical research, the Trust plays a pivotal role in conducting innovative clinical trials that aim to improve health outcomes for women and their families. With a multidisciplinary approach, the Trust collaborates with various stakeholders to ensure rigorous scientific standards and ethical practices are upheld in all research initiatives. Its focus on patient-centered care and commitment to excellence positions Birmingham Women's NHS Foundation Trust as a key contributor to advancements in women's health and medical research.

Locations

Birmingham, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Nahed Hammadieh, MD,MRCOG

Principal Investigator

Assisted Conception Unit

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials